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Abstract

The effects of chronic oral administration
of a standardized Ginkgo biloba extract
(GBE) on the performance of two
classical memory tasks was investigated.
Long-Evans rats, 3 and 16 months of age,
received daily doses of diets with or
without GBE (100 mg/kg) for a period of 6
weeks before testing and throughout the
experiment. A 2 x 2 (Age x Treatment)
ANOVA indicated that GBE treatment
prevented learning on a radial maze task
as measured by number of days to
criterion, F(1, 28) = 5.73, p < .05. A 2 x 2
x 19 (Age x Treatment x Day) ANOVA was
used to analyze the number of correct
responses from Days 1 to 19. The results
showed an interaction between Age and
Treatment F(1, 28) = 6.34, p <. 05;
namely young treated rats performed
worse than other groups. Analysis of
response frequency by a 2 x 2 (Age x
Treatment) ANOVA revealed a significant
interaction F(1, 28) = 4.41, p < .05, and
a subsequent post hoc test indicated that
the young treatment group responded
notably more than the old groups.
Measured performance on a one-way
passive avoidance task indicated that
neither treatment nor age had an effect.
The results suggest that at the prescribed
dose level and duration, GBE impairs
performance on a radial maze task,
particularly in young rats.
The Ginkgo biloba tree is one of
the oldest species of trees alive today. For
over 5000 years, Chinese medicine has
recognized the medicinal uses of Ginkgo
biloba leaves to "benefit the brain" and
allay a variety of pathological symptoms
(Murray, 1990). Pharmacological and
clinical studies published over the last few
years have demonstrated the efficacy of a
standardized Ginkgo biloba extract (GBE)
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for the treatment of a wide variety of age
related conditions like edema, impotence,
vertigo, tennitis, vigilance, and a number
of pathologies associated with memory
disorders. Currently, GBE is one of the
most prescribed medicines in Europe for
the treatment of pathological conditions.
GBE's are made from the green
leaves of the Ginkgo biloba tree. The
active constituents of the standardized
extracts include 24% glucoflavonoids, 6%
terpenes (bilobalides and ginkgolides),
and proanthocyanidies. Organic acids are
added primarily to increase the
compounds solubility and facilitate
circulatory transportation to vital organs
(Drieu, 1988). In regards to behavioral
dysfunctions associated with memory,
studies (e.g., Taylor, 1988) have
suggested that GBE causes numerous
morphological and biochemical changes
in the brain which improve the memory of
individuals suffering from Alzheimer's
Disease, cerebral vascular insufficiency,
and those affected by normal senescent
memory loss. It is well known that
memory dysfunctions result from a
decline of cholinergic muscarinic activity
in the hippocampus (Deutch, 1971; Gold
& McGraugh, 1975).
Numerous studies have cited
similar declines in the brains of those
suffering from forms of presenile and
senile dementia (Bartus, Dean, Beer, &
Lippa, 1982; Davis & Moloney, 1976).
An inverse relationship between age and
acetylcholine transmission has also been
identified in animals and humans (Bartus
et al., 1982; Taylor, 1988). Taylor has
demonstrated that chronic oral
administration of GBE increases the
number of post-synaptic muscarinic
acetylcholine receptors in the
hippocampus regardless of age, but more
so in aged rats. Cognitive deficits can also
result from a reduction in cerebral blood
flow, and GBE has been recognized for its
ability to dilate arteries leading to the
brain, thereby restoring cerebral
circulation of glucose and oxygen which
is essential for proper brain function
(Karcher, Zageman, & Krieglstein, 1984;
Rapin, Lamproglou, Dreiu, & Defeudis, in
press).
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Serotonin is another neurotransmitter that has been implicated as
playing a critical role in memory;
however, the correlation between
serotonin levels and memory is less clear.
In man and rodents, serotonin levels
decrease in the cerebral cortex with age
(Gottfries, 1979; Huguet, Drieu, & Piriou,
1994). Lower serotoninergic activity has
been identified as a major contributor to
mood disorders like depression, which are
more prevalent with age. Coupling the
facts that one of the primary symptoms of
depression is memory impairment, and 5HT-ergic agonists (e.g., tricyclics and
MAO inhibitors) alleviate this symptom,
the correlation between cerebral serotonin
and memory appears to be positive. In this
regard, recent studies by Huguet et al.
(1994) demonstrated that treatment of
GBE increases the number of 5-HT1A
receptors of the cerebral cortex in
senescent rats; nonsignificant increases in
young rats were also found.
Elucidation of the mechanisms by
which GBE restores cerebral neuronal
systems is not complete. Flavonoid
derivatives are known to exhibit free
radical scavenger activity which prevents
lipid peroxidation of cell membranes
(Pincemail & Deby, 1988). Neuronal
membranes are uniquely more susceptible
to peroxidation due to their high density
of polyunsaturated fatty lipids. This
scavenger activity alone maintains the
relationship between neuronal membranes
and receptors and also maintains
membrane fluidity. Furthermore, it is
believed that GBE enhances receptor
density by restoring essential protein
synthesis (Huguet et al., 1994).
In addition to cerebral modulation,
a few recent studies indicate that GBE
affects the endocrine system by reducing
plasma corticoids and catecholamines
released by the adrenal cortex and
medulla, respectively (Rapin et al., in
press). Since elevated levels of these
hormones are associated with anxiety-like
activity and the disruption of learning
performance (Hurwitz, Robinson, &
Barofsky, 1971), GBE is said to exert
"anti-stress" activity. By decreasing

anxiety levels, GBE can prevent a
number of maladaptive learning behaviors
ranging from hyperactivity to an inability
to make decisions (LePoncin, Aymonod,
Brillon, Pesquies, & Rapin, 1980). In
humans, the detrimental effects of anxiety
are more pronounced in older subjects and
can be particularly deleterious to learning.
Clinical studies have demonstrated
that chronic GBE treatment alleviates
behavioral deficits associated with
memory in individuals suffering from
senility and many types of dementia
(GeBner, Voelp, & Klasser, 1985;;
Taillandier et al., 1988; Warburton, 1988).
Most positive effects of GBE result after
subjects receive treatment for at least 3-4
weeks, and the duration of treatment is
positively correlated with the beneficial
effects (e.g., Taillandier et al., 1988). A
smaller number of studies have shown that
treatments can also improve the memory
and performance on tasks in normal young
volunteers (Subhan & Hindmach, 1984).
Although many studies have
examined the biochemical and
morphological changes in rodents, few
have investigated how these effects
determine behavior. As a whole, the cited
studies indicate that GBE primarily causes
restorative physical changes in older
subjects in biological systems important to
the memory process. The present study
was aimed at investigating the efficacy of
chronic oral treatment of GBE on
performance of memory tasks in young
and old rats. Given this information, one
would also expect to witness improved
performance on memory tasks in older
subjects.
Experiment 1
Method
Subjects. The subjects were 32
experimentally naive female Long-Evans
rats weighing between 181-359 g at the
beginning of the experiment and were
classified as either young or aged,
approximately 3 and 16 months old,
respectively. Rats were housed separately
on a 12 hr light-dark cycle in a
temperature controlled room (23 °C). One
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week prior to shaping, subjects were put
on a 23 hr food deprivation schedule.
Weights were monitored, and animals
were given additional rations if their body
weight fell below 85% of free-feeding
weight.
GBE Treatment. Six weeks prior
to shaping, both young and aged rats were
assigned to either an experimental or
control group. The young experimental
(YE) and old experimental (OE) groups
were placed on a GBE-rich diet; each rat
received 100 mg/kg of GBE daily. The
supplement, marketed by Enzymatic
Therapy®, is standardized to contain 24%
Ginkgoheterosides. Weighed doses were
masked in approximately 2 g of instant
whipped potatoes and 0.2 g of sucrose.
Young control (YC) and aged control
(AC) groups received the potato-sucrose
mixture without added GBE. Subjects
were fed the supplement at 8:00 am daily
for the duration of the experiment
(approximately 11 weeks) and were
weighed every third day to verify
appropriate dose. Dose levels were based
on previous studies (e.g., Taylor, 1988).
Materials. The rats were tested on
an elevated radial maze similar to the one
described by Olton and Samuelson (1976).
This apparatus has long been recognized
as a valid tool for investigating the
influence of pharmacological compounds
on memory (Olton, 1987). The maze was
elevated 94 cm above the floor. Each arm
was 7 cm wide and extended 85 cm from
the center platform; a 2.5 cm wall
surrounded each arm, and a small cup was
placed in each arm. An enclosed box over
the center platform could be raised or
lowered to control entry into all arms. The
experimenter regulated this box from a
separate room via a system of fishlines;
rats were visually monitored by camera.
Procedures. Each rat was
randomly assigned four different arms
which were baited at the beginning of
each trial with two Bioserve® pellets.
These assigned arms remained constant
for each rat throughout shaping and test
trails. Testing occurred 7 days a week
between 2 p.m. - 6 p.m. The order of
testing each group (i.e., YC, OC, YE, and
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OE) was rotated each day, and the maze
was washed daily with dilute ammonia
water at the end of testing.
Shaping trials were conducted on
Days 1-10, during which all cups (baited
and nonbaited), were daily placed
successively farther away from the central
platform. Five Bioserve® pellets were
placed in the arms with the baited cups;
leading from the center platform to each
cup. At the beginning of a trial, each
animal was placed on the central platform
under the enclosed box. When the box
was raised, the rat was allowed to explore
the maze for 3 min, during which the
number of arm entries was recorded. The
criterion for arm entry was placement of
all 4 feet into an arm. On Days 5-10,
subjects explored the maze for 3 min or
until all arms were entered. Those subjects
with fewer than two entries per session,
were physically placed at various
locations in the maze and encouraged to
explore the maze. By Day 10 all rats were
responding with approximately the same
frequency.
Testing was conducted from Day
11-41. All cups were positioned at the
distal end of each arm, and no Bioserve®
tablets led to baited arms. Testing
procedures were similar to shaping trials,
however each rat was allowed only four
arm entries; upon return to the central
platform after the forth entry, the enclosed
box was lowered. All subjects were tested
from Days 11-30, during which the
number of correct responses was recorded.
The number of days to criterion for each
individual subject was also recorded. A
subject reached criterion when she made
three of four correct responses for three
consecutive days. After Day 30, testing
continued only for those subjects who did
not reach the criterion. By Day 41, all
subjects had reached the criterion.
Results
Results from a 2 x 2 (Age x
Treatment) analysis of variance on the
response frequency during Days 1 to 5,
demonstrated significant age effects, F(1,
28) = 16.13, p < .001, and a significant
interaction, F(1, 28) = 4.41, p < .05. Cell
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means for the YC, YE, OC, and OE
groups were 42.0, 59.6, 31.8, and 26.9,
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The mean number of days to
criterion for each group is displayed in
Figure 2. Means of 7.38 and 13.56 days,
respectively, were needed for the control
and experiment groups to reach criterion.
A 2 x 2 (Age x Treatment) analysis of
variance verified that the experimental
group needed significantly more days than
the control group to reach criterion, F(1,
28) = 5.73, p < .05. The mean days to
criterion for individual groups were as
follows: YC, 4.88; YE, 15.50; OC, 9.88;
and OE, 11.63.
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Figure I. Mean response frequencies during
shaping phase of radial maze task.

respectively (See Figure 1). A Scheffe
post hoc test (p < .05) showed that the YE
group response frequency was
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OE

Figure 3. Overall mean number of correct
responses per day during test phase of radial arm
maze.

Analysis of the number of correct
responses from Days 1 to 19 was
conducted by a 2 x 2 x 19 ( Age x
Treatment x Day) split-plot analysis of
variance. The results showed significant

Figure 2. Mean number of days to criterion on
radial maze task.

significantly higher than the OE and OC,
F(3, 28) = 7.26, p < .05.

Figure 4. Mean number of correct responses
during test phase of radial arm maze, Days 1 - 19.
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treatment effects, F(1, 28) = 10.43, p < .01
and a significant two-way interaction
between age and treatment F(1, 28) =
6.34, p < .05. Cell means for the YC, YE,
OC, and OE groups were 3.06, 2.32, 2.73,
and 2.64, respectively (See Figure 3). A
Scheffe post hoc test (p < .05) showed that
the YE group's average number of correct
responses during the 19-day test period
was significantly lower than the other
three groups, F(2, 54) = 14.18, p < .001
(See Figure 4).
Discussion
The results from the radial maze
testing phase indicate that at the
prescribed dose and treatment duration
GBE clearly impaired learning. This is
noted by the fact that as a combined
group, both YE and OE took a
significantly longer time to reach the
criterion than the control groups.
Although no significant interaction was
calculated, the discrepancy between the
number of days to criterion between the
YE and YC was much larger than between
OE and OC, suggesting that GBE had a
more deleterious effect on the young rats
than the old. Evaluation of the group
performance over 19 days of testing
concludes that the YE performed
significantly worse than the other groups.
This selective effect is contrary to
expectations based on past studies which
indicate that at this dose, critical
biochemical and morphological changes
occur primarily in old rats, which should
theoretically improve memory and
learning.
A plausible explanation can be
surmised if one takes into account the
positive correlation between treatment and
activity levels found in the young rats of
this study. It is well established that the
relationship between arousal and
performance is curvilinear, and although a
certain amount of arousal is required for
the display of adaptive behaviors, too
much arousal can lead to overactivity and
poor performance. LePoncin et al. (1980)
revealed that over arousal can also lead to
hypoactivity and poor performance. This
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over arousal may explain why the OE
group took longer to reach the criterion,
and their response frequency tended to be
lower than other groups.
Another possible explanation for
the adverse effects of treatments may be
related to dose levels. As with any drug
used to treat behavioral or physical
problems, proper dose levels are critical
for desired results; in fact, improper levels
can cause adverse conditions. In this
regard, studies that have found positive
effects on elderly humans (e.g.,
Taillandier et al., 1988) have used daily
doses ranging from 120-600 mg/day or 212 mg/kg of body weight. In contrast,
most studies on the biological effects of
GBE in rats use a much higher dose of
approximately 50-100 mg/kg of body
weight. It is quite possible that although
GBE had a restorative effect on neuronal
systems known to be important in
memory, excessive levels of GBE
adversely affected other biological factors
important for proper memory,
performance functions, or both.
Experiment 2
Method
Subjects. Same as Experiment 1.
Testing of all subjects was conducted after
completion of Experiment 1. One OE
subject was euthanized prior to
Experiment 2, due to rapid growth of a
tumor which inhibited free mobility.
GBE Treatment. The start of
Experiment 2 was conducted 11 weeks
after the experimental groups, YE and OE,
were placed on treatment; treatment
continued through Experiment 2.
Materials. The second experiment
was conducted with a one-way passive
avoidance apparatus similar to one
described by Ader, Weijnen, and
Moleman (1972). The apparatus consisted
of a 24 x 28 x 38 cm enclosed box and a 6
x 24 cm elevated runway platform leading
to a 6 x 6 cm opening into the box.
Entrance into the box was controlled by a
guillotine door. The runway was covered
with wire mesh and the floor of the
enclosed box was constructed with 4 mm
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proportion of retained learning.
Significance was reached for the main
effect of Time, F(2, 50) = 34.93, p < .001.
The proportion of retained learning for

steel rods spaced 1.4 cm apart from each
other. The box was elevated 94 cm above
the floor and maintained in a dark room
with the exception of a 40-W lamp fixed
35 cm above the runway.
Procedures.
Testing was
conducted over the course of two days. On
the first day, each animal was separately
placed in the box with the door closed for
a period of 2 min. This was followed by a
single trial in which the rat was placed on
an elevated runway (facing opposite the
door) and allowed to enter the box for 10
s. Upon entry (4 feet on the interior grid
floor), a guillotine door was lowered,
leaving enough height for its tail.
On Day 2, each rat was given three
such trials, during which the latency to
enter the box was recorded. Between
trials, rats were placed in an adjacent cage
for a 30 s intertrial interval. On the third
of these trials, the rat received a single 1 s,
0.50 mA electric shock through the grid
floor of the cage immediately after
entering. Shocks were produced by 25-V
AC source delivered through a variable
series resistor. Retention was tested when
the rats were again placed on the elevated
runway 30 s, 1 hr, and 20 hr after the
shock trial. Subjects were allowed a
maximum 120 s retention interval, and no
shock was presented on retention trials.

each interval was as follows: 30 s .80; 1 hr
.49; and 20 hr .19. A Scheffe post hoc test
(p < .05) showed a significant difference
in the proportions between all time
intervals, F(2, 84) = 20.08, p < .001 (See
Figure 5). Other main effects and
interactions showed no significance.

Results

Discussion

Two OC subjects refused to enter
the darkened box when placed on the
outside platform for preshock latency
measurement, so their measurements
could not be tabulated in the results. To
control for differences in the preshock
latency times, measurements of the
postshock retention intervals were
converted to proportions of retention by
dividing the postshock latency minus
preshock latency factor by 120 s minus
preshock latency. All negative
proportions, which resulted when
postshock latencies were less than
preshock latencies, were assigned a value
of 0.0, since they reflected no retention. A
2 x 2 x 3 (Age x Treatment x Time)
between within split-plot analysis of
variance was used to analyze the

The significant differences in the
proportions of retained learning suggest
that over time, rats were less likely to
remember the possible adverse effects of
entering the dark box. Since no significant
age differences were revealed between
control groups in Experiment 1 or
Experiment 2, one may conclude that
either these tests are not sensitive to age
differences in recall and memory or no
memory differences exist between age
groups. It is possible that at 16 months of
age, the biological systems critical for
proper memory function have not been
significantly altered by the detrimental
effects of aging. In fact, many of the
studies investigating age differences in
rats use subjects that are 18 months of age
or older.

0.8 7
E 0.7
E
0.s=
t- 0.5
'75 0.4 C
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30s.

1 hr.
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Figure 5. Mean proportion of retained learning
over trial intervals.
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General Discussion
In conclusion, the present study
suggests that repeated oral administration
of a standardized GBE can have negative
effects on the performance of a memory
task in young and old rats. To date, no
known studies have been published which
demonstrate similar findings. In light of
these results, it seems important that
future studies determine the appropriate
dose needed for positive results and the
relationship between the morphological
and biochemical modifications caused by
GBE treatment and the resulting
behavioral changes.
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